33. Darby SC, Doll R, Gill SK, et al.: Long term mortality after a single treatment course with X-rays in patients treated for ankylosing spondylitis. Br J Cancer 55(2):179-190, 1987.

34. Urowitz MB, Rider WD: Myeloproliferative disorders in patients with rheumatoid arthritis treated with total body irradiation. Am J Med 78(1A):60-64, 1985.

35. Hempelmann LH, Hall WJ, Phillips M, et al.: Neoplasms in persons treated with X-rays in infancy: fourth survey in 20 years. J Natl Cancer Inst 55(3):519-530, 1975.

36. Griem ML, Kleinerman RA, Boice JD Jr, et al.: Cancer following radiotherapy for peptic ulcer. J Natl Cancer Inst 86(11):842-849, 1994.

37. Andersson MB, Carstensen B, Visfeldt J: Leukemia and other related hematological disorders among Danish patients exposed to Thorotrast. Radiat Res 134(2):224-233, 1993.

38. Boice JD Jr, Morin MM, Glass AG, et al.: Diagnostic X-ray procedures and risk of leukemia, lymphoma, and multiple myeloma. JAMA 265(10):1290-1294, 1991.

39. Davis FG, Boice JD Jr, Hrubec Z, et al.: Cancer mortality in a radiation-exposed cohort of Massachusetts tuberculosis patients. Cancer Res 49(21):6130-6136, 1989.

40. Savitz DA: Overview of epidemiologic research on electric and magnetic fields and cancer. Am Ind Hyg Assoc J 54(4):197-204, 1993.

41. Feychting M: Occupational exposure to electromagnetic fields and adult leukaemia: a review of the epidemiologi-cal evidence. Radiat Environ Biophys 35(4):237-242, 1996.

42. Li CY, Theriault G, Lin RS: Epidemiological appraisal of studies of residential exposure to power frequency magnetic fields and adult cancers. Occup Environ Med 53(8):505-510, 1996.

43. Gundestrup M, Storm HH: Radiation-induced acute myeloid leukaemia and other cancers in commercial jet cockpit crew: a population-based cohort study. Lancet 354(9195):2029-2031, 1999.

44. Band PR, Le ND, Fang R, et al.: Cohort study of Air Canada pilots: mortality, cancer incidence, and leukemia risk. Am J Epidemiol 143(2):137-143, 1996.

45. Brandt L, Nilsson PG, Mitelman F: Occupational exposure to petroleum products in men with acute non-lym-phocytic leukaemia. Br Med J 1(6112):553, 1978.

46. Rinsky RA, Smith AB, Hornung R, et al.: Benzene and leukemia. An epidemiologic risk assessment. N Engl J Med 316(17):1044-1050, 1987.

47. Shore RE, Gardner MJ, Pannett B: Ethylene oxide: an assessment of the epidemiological evidence on carcino-genicity. Br J Ind Med 50(11):971-997, 1993.

48. Cole P, Delzell E, Acquavella J: Exposure to butadiene and lymphatic and hematopoietic cancer. Epidemiology 4(2):96-103, 1993.

49. Santos-Burgoa C, Matanoski GM, Zeger S, et al.: Lymphohematopoietic cancer in styrene-butadiene polymerization workers. Am J Epidemiol 136(7):843-854, 1992.

50. Kogevinas M, Ferro G, Andersen A, et al.: Cancer mortality in a historical cohort study of workers exposed to styrene. Scand J Work Environ Health 20(4):251-261, 1994.

51. Kolstad HA, Lynge E, Olsen J, et al.: Incidence of lym-phohematopoietic malignancies among styrene-exposed workers of the reinforced plastics industry. Scand J Work Environ Health 20(4):272-278, 1994.

52. Richardson S, Zittoun R, Bastuji-Garin S, et al.: Occupational risk factors for acute leukaemia: a case-control study. Int J Epidemiol 21(6):1063-1073, 1992.

53. Kristensen P, Andersen A, Irgens LM, et al.: Incidence and risk factors of cancer among men and women in

Norwegian agriculture. Scand J Work Environ Health 22(l):14-26, 1996.

54. Figa-Talamanca I, Mearelli I, Valente P, et al.: Cancer mortality in a cohort of rural licensed pesticide users in the province of Rome. Int J Epidemiol 22(4):579-583, 1993.

55. Alavanja MC, Hoppin JA, Kamel F: Health effects of chronic pesticide exposure: cancer and neurotoxicity*3. Annu Rev Public Health 25:155-197, 2004.

56. Siegel M: Smoking and leukemia: evaluation of a causal hypothesis. Am J Epidemiol 138(1):1-9, 1993.

57. Brownson RC, Novotny TE, Perry MC: Cigarette smoking and adult leukemia. A meta-analysis. Arch Intern Med 153(4):469-475, 1993.

58. Korte JE, Hertz-Picciotto I, Schulz MR, et al.: The contribution of benzene to smoking-induced leukemia. Environ Health Perspect, 108(4):333-339, 2000.

59. Vineis P, Alavanja M, Buffler P, et al.: Tobacco and cancer: recent epidemiological evidence. J Natl Cancer Inst 96(2):99-106, 2004.

60. Moorman AV, Roman E, Cartwright RA, et al.: Smoking and the risk of acute myeloid leukaemia in cytogenetic subgroups. Br J Cancer 86(1):60-62, 2002.

61. Adami J, Nyren O, Bergstrom R, et al.: Smoking and the risk of leukemia, lymphoma, and multiple myeloma (Sweden). Cancer Causes Control 9(1):49-56, 1998.

62. Rauscher GH, Shore D, Sandler DP: Hair dye use and risk of adult acute leukemia. Am J Epidemiol 160(1):19-25, 2004.

63. Altekruse SF, Henley SJ, Thun MJ: Deaths from hematopoietic and other cancers in relation to permanent hair dye use in a large prospective study (United States). Cancer Causes Control 10(6):617-625, 1999.

64. Grodstein F, Hennekens CH, Colditz GA, et al.: A prospective study of permanent hair dye use and hematopoietic cancer. J Natl Cancer Inst 86(19):1466-1470, 1994.

65. Tajima K, Cartier L: Epidemiological features of HTLV-I and adult T cell leukemia. Intervirology 38(3-4):238-246, 1995.

66. Rowley JD, Golomb HM, Vardiman J: Acute leukemia after treatment of lymphoma. N Engl J Med 297(18):1013, 1977.

67. Kaldor JM, Day NE, Clarke EA, et al.: Leukemia following Hodgkin's disease. N Engl J Med 322(1):7-13, 1990.

68. Kantarjian HM, Keating MJ: Therapy-related leukemia and myelodysplastic syndrome. Semin Oncol 14(4):435-443, 1987.

69. Rowley JD, Olney HJ: International workshop on the relationship of prior therapy to balanced chromosome aberrations in therapy-related myelodysplastic syndromes and acute leukemia: overview report. Genes Chromosomes Cancer 33(4):331-345, 2002.

70. Cadman EC, Capizzi RL, Bertino JR: Acute non-lymphocytic leukemia: a delayed complication of Hodgkin's disease therapy: analysis of 109 cases. Cancer 40(3):1280-1296, 1977.

71. Pedersen-Bjergaard J, Philip P, Pedersen NT, et al.: Acute non-lymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome secondary to treatment of other malignant diseases. II: Bone marrow cytology, cytogenetics, results of HLA typing, response to antileukemic chemotherapy, and survival in a total series of 55 patients. Cancer 54(3):452-462, 1984.

72. Le Beau MM, Albain KS, Larson RA, et al.: Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlym-phocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7. J Clin Oncol 4(3):325-345, 1986.

73. Heim S, Mitelman F: Cytogenetic analysis in the diagnosis of acute leukemia. Cancer 70(suppl 6):1701-1709,

Was this article helpful?

0 0
Arthritis Relief and Prevention

Arthritis Relief and Prevention

This report may be oh so welcome especially if theres no doctor in the house Take Charge of Your Arthritis Now in less than 5-Minutes the time it takes to make an appointment with your healthcare provider Could you use some help understanding arthritis Maybe a little gentle, bedside manner in your battle for joint pain relief would be great Well, even if you are not sure if arthritis is the issue with you or your friend or loved one.

Get My Free Ebook

Post a comment